This 2023 Recommendation Statement from the US Preventive Services Task Force recommends screening for anxiety disorders in adults, including pregnant and postp
This 2023 Recommendation Statement from the US Preventive Services Task Force recommends screening for depression in the adult population, including pregnant an
This 2022 Recommendation Statement from the US Preventive Services Task Force concludes that the current evidence is insufficient to assess the balance of benef
This Viewpoint reviews the evidence gaps reported to Congress by the US Preventive Services Task Force (USPSTF) in 2021 on improving health inequities in preven
This 2022 Recommendation Statement from the US Preventive Services Task Force recommends screening for anxiety in children and adolescents aged 8 to 18 years (B